Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity

Bibliography

• Paulose-Ram R, Hirsch R, Dillon C, Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III). Pharmacoepidemiol Drug Saf 2003;12:315-26
   PubMed Web of Science ®Google Scholar
• Singh G, Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol Suppl 1999;56:18-24
   PubMedGoogle Scholar
• Bloom BS. Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis. Am J Med 1988;84:20-4
   PubMedGoogle Scholar
• Rubenstein JH, Laine L. Systematic review: the hepatotoxicity of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2004;20:373-80
   PubMed Web of Science ®Google Scholar
• Mabee CL, Mabee SW, Baker PB, Fulminant hepatic failure associated with etodolac use. Am J Gastroenterol 1995;90:659-61
   PubMed Web of Science ®Google Scholar
• McCormick PA, Kennedy F, Curry M, COX 2 inhibitor and fulminant hepatic failure. Lancet 1999;353:40-1
   PubMed Web of Science ®Google Scholar
• Teoh NC, Farrell GC. Hepatotoxicity associated with non-steroidal anti-inflammatory drugs. Clin Liver Dis 2003;7:401-13
   PubMedGoogle Scholar
• Daly AK, Aithal GP, Leathart JB, Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes. Gastroenterology 2007;132:272-81
   PubMed Web of Science ®Google Scholar
• Suzuki A, Andrade RJ, Bjornsson E, Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work. Drug Saf 2010;33:503-22
   PubMed Web of Science ®Google Scholar
• Andrade RJ, Lucena MI, Fernandez MC, Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005;129:512-21
   PubMed Web of Science ®Google Scholar
• Bessone F. Non-steroidal anti-inflammatory drugs: what is the actual risk of liver damage? World J Gastroenterol 2010;16:5651-61
   PubMed Web of Science ®Google Scholar
• Bjornsson E. Review article: drug-induced liver injury in clinical practice. Aliment Pharmacol Ther 2010;32:3-13
   PubMed Web of Science ®Google Scholar
• Sgro C, Clinard F, Ouazir K, Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002;36:451-5
   PubMed Web of Science ®Google Scholar
• Bjornsson E, Jerlstad P, Bergqvist A, Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scand J Gastroenterol 2005;40:1095-101
   PubMed Web of Science ®Google Scholar
• Bjornsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 2005;42:481-9
   PubMed Web of Science ®Google Scholar
• Andrade RJ, Agundez JA, Lucena MI, Pharmacogenomics in drug induced liver injury. Curr Drug Metab 2009;10:956-70
   PubMed Web of Science ®Google Scholar
• Laine L, Goldkind L, Curtis SP, How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial. Am J Gastroenterol 2009;104:356-62
   PubMed Web of Science ®Google Scholar
• Chalasani N, Bjornsson E. Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology 2010;138:2246-59
   PubMed Web of Science ®Google Scholar
• Lucena MI, Andrade RJ, Kaplowitz N, Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. Hepatology 2009;49:2001-9
   PubMed Web of Science ®Google Scholar
• Henry D, Lim LL, Garcia Rodriguez LA, Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996;312:1563-6
   PubMed Web of Science ®Google Scholar
• Traversa G, Bianchi C, Da Cas R, Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs. BMJ 2003;327:18-22
   PubMed Web of Science ®Google Scholar
• Tolman KG. Hepatotoxicity of non-narcotic analgesics. Am J Med 1998;105:13S-19S
   PubMedGoogle Scholar
• Geoffroy P, Carteret E, Salagnac V, Hepatitis caused by diflunisal (Dolobis). Apropos of a case. Therapie 1987;42:253
   PubMed Web of Science ®Google Scholar
• Stennet DJ, Simonson W, Hall CA. Fenoprofen-induced hepatotoxicity. Am J Hosp Pharm 1978;35:901
   PubMedGoogle Scholar
• Lacroix I, Lapeyre-Mestre M, Bagheri H, Nonsteroidal anti-inflammatory drug-induced liver injury: a case-control study in primary care. Fundam Clin Pharmacol 2004;18:201-6
   PubMed Web of Science ®Google Scholar
• Delgadillo Duarte J, Videla Ces S, Navas Ramirez J, Fosfosal-induced hepatitis. Rev Clin Esp 1994;194:203-4
   PubMedGoogle Scholar
• Singer JB, Lewitzky S, Leroy E, A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury. Nat Genet 2010;42:711-14
   PubMed Web of Science ®Google Scholar
• Somchit N, Sanat F, Gan EH, Liver injury induced by the non-steroidal anti-inflammatory drug mefenamic acid. Singapore Med J 2004;45:530-2
   PubMedGoogle Scholar
• Boboc B, Larrey D, Bernuau J, Acute hepatitis probably caused by niflumic acid. Gastroenterol Clin Biol 1987;11:175-6
   PubMed Web of Science ®Google Scholar
• Lapeyre-Mestre M, de Castro AM, Bareille MP, Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems. Fundam Clin Pharmacol 2006;20:391-5
   PubMed Web of Science ®Google Scholar
• Macia MA, Carvajal A, del Pozo JG, Hepatotoxicity associated with nimesulide: data from the Spanish Pharmacovigilance System. Clin Pharmacol Ther 2002;72:596-7
   PubMed Web of Science ®Google Scholar
• Available from: http://www.aemps.es/profHumana/observatorio/docs/AINE.pdf
   Google Scholar
• Available from: http://www.spanishdili.uma.es/index.php?option=com_content&view=article&id=92&Itemid=83&lang=en
   Google Scholar
• Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 1990;11:272-6
   PubMed Web of Science ®Google Scholar
• Available from: http://www.saeconsortium.org/?q=node/23
   Google Scholar
• Chalasani N, Fontana RJ, Bonkovsky HL, Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008;135:1924-34, 34 e1-4
   PubMed Web of Science ®Google Scholar
• Ghabril M, Chalasani N, Bjornsson E. Drug-induced liver injury: a clinical update. Curr Opin Gastroenterol 2010;26:222-6
   PubMed Web of Science ®Google Scholar
• Zimmerman HJ. Drug-induced liver disease. Clin Liver Dis 2000;4:73-96, vi
   PubMedGoogle Scholar
• Andrade RJ, Lucena MI, Kaplowitz N, Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry. Hepatology 2006;44:1581-8
   PubMed Web of Science ®Google Scholar
• Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov 2005;4:489-99
   PubMed Web of Science ®Google Scholar
• Russmann S, Kullak-Ublick GA, Grattagliano I. Current concepts of mechanisms in drug-induced hepatotoxicity. Curr Med Chem 2009;16:3041-53
   PubMed Web of Science ®Google Scholar
• Russmann S, Jetter A, Kullak-Ublick GA. Pharmacogenetics of drug-induced liver injury. Hepatology 2010;52:748-61
   PubMed Web of Science ®Google Scholar
• Daly AK. Drug-induced liver injury: past, present and future. Pharmacogenomics 2010;11:607-11
   PubMed Web of Science ®Google Scholar
• Agundez JA, Garcia-Martin E, Martinez C. Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: is a combination of pharmacogenomics and metabolomics required to improve personalized medicine? Expert Opin Drug Metab Toxicol 2009;5:607-20
   PubMed Web of Science ®Google Scholar
• Lammert C, Einarsson S, Saha C, Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals. Hepatology 2008;47:2003-9
   PubMed Web of Science ®Google Scholar
• Dupont I, Berthou F, Bodenez P, Involvement of cytochromes P-450 2E1 and 3A4 in the 5-hydroxylation of salicylate in humans. Drug Metab Dispos 1999;27:322-6
   PubMed Web of Science ®Google Scholar
• Agundez JA, Martinez C, Perez-Sala D, Pharmacogenomics in aspirin intolerance. Curr Drug Metab 2009;10:998-1008
   PubMed Web of Science ®Google Scholar
• Agundez JA. Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab 2004;5:211-24
   PubMed Web of Science ®Google Scholar
• Agundez JA, Martinez C, Garcia-Martin E, Cytochrome P450 CYP2C9 polymorphism and NSAID-related acute gastrointestinal bleeding. Gastroenterology 2007;133:2071-2
   PubMed Web of Science ®Google Scholar
• Blanco G, Martinez C, Ladero JM, Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding. Pharmacogenet Genomics 2008;18:37-43
   PubMed Web of Science ®Google Scholar
• Garcia-Martin E, Martinez C, Ladero JM, Influence of cytochrome P450 CYP2C9 genotypes in lung cancer risk. Cancer Lett 2002;180:41-6
   PubMed Web of Science ®Google Scholar
• Martinez C, Garcia-Martin E, Ladero JM, Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk. Carcinogenesis 2001;22:1323-6
   PubMed Web of Science ®Google Scholar
• Garcia-Martin E, Martinez C, Ladero JM, Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals. Mol Diagn Ther 2006;10:29-40
   PubMed Web of Science ®Google Scholar
• Garcia-Martin E, Martinez C, Tabares B, Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms. Clin Pharmacol Ther 2004;76:119-27
   PubMed Web of Science ®Google Scholar
• Dai D, Zeldin DC, Blaisdell JA, Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid. Pharmacogenetics 2001;11:597-607
   PubMedGoogle Scholar
• Soyama A, Saito Y, Komamura K, Five novel single nucleotide polymorphisms in the CYP2C8 gene, one of which induces a frame-shift. Drug Metab Pharmacokinet 2002;17:374-7
   PubMedGoogle Scholar
• Martinez C, Garcia-Martin E, Alonso-Navarro H, Changes at the CYP2C locus and disruption of CYP2C8/9 linkage disequilibrium in patients with essential tremor. Neuromolecular Med 2007;9:195-204
   PubMed Web of Science ®Google Scholar
• Martinez C, Garcia-Martin E, Blanco G, The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects. Br J Clin Pharmacol 2005;59:62-9
   PubMed Web of Science ®Google Scholar
• Wen X, Wang JS, Backman JT, Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively. Drug Metab Dispos 2002;30:631-5
   PubMed Web of Science ®Google Scholar
• Garcia-Martin E, Pizarro RM, Martinez C, Acquired resistance to the anticancer drug paclitaxel is associated with induction of cytochrome P450 2C8. Pharmacogenomics 2006;7:575-85
   PubMed Web of Science ®Google Scholar
• Martinez C, Garcia-Martin E, Pizarro RM, Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy. Br J Cancer 2002;87:681-6
   PubMed Web of Science ®Google Scholar
• Aithal GP, Day CP, Leathart JB, Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced hepatitis. Pharmacogenetics 2000;10:511-18
   PubMedGoogle Scholar
• Pachkoria K, Lucena MI, Ruiz-Cabello F, Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI). Br J Pharmacol 2007;150:808-15
   PubMed Web of Science ®Google Scholar
• Sevilla-Mantilla C, Ortega L, Agundez JA, Leflunomide-induced acute hepatitis. Dig Liver Dis 2004;36:82-4
   PubMedGoogle Scholar
• Restrepo JG, Garcia-Martin E, Martinez C, Polymorphic drug metabolism in anaesthesia. Curr Drug Metab 2009;10:236-46
   PubMed Web of Science ®Google Scholar
• Raucy JL, Lasker JM, Lieber CS, Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch Biochem Biophys 1989;271:270-83
   PubMed Web of Science ®Google Scholar
• Zaher H, Buters JT, Ward JM, Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice. Toxicol Appl Pharmacol 1998;152:193-9
   PubMed Web of Science ®Google Scholar
• Hayashi S, Watanabe J, Kawajiri K. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 1991;110:559-65
   PubMed Web of Science ®Google Scholar
• Hu Y, Oscarson M, Johansson I, Genetic polymorphism of human CYP2E1: characterization of two variant alleles. Mol Pharmacol 1997;51:370-6
   PubMed Web of Science ®Google Scholar
• Martinez C, Galvan S, Garcia-Martin E, Variability in ethanol biodisposition in whites is modulated by polymorphisms in the ADH1B and ADH1C genes. Hepatology 2010;51:491-500
   PubMed Web of Science ®Google Scholar
• Sun F, Chen Y, Xiang Y, Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis. Int J Tuberc Lung Dis 2008;12:994-1002
   PubMed Web of Science ®Google Scholar
• Ladero JM, Martinez C, Garcia-Martin E, Polymorphisms of the glutathione S-transferases mu-1 (GSTM1) and theta-1 (GSTT1) and the risk of advanced alcoholic liver disease. Scand J Gastroenterol 2005;40:348-53
   PubMed Web of Science ®Google Scholar
• Martinez C, Martin F, Fernandez JM, Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics 2006;7:711-18
   PubMed Web of Science ®Google Scholar
• Lucena MI, Andrade RJ, Martinez C, Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury. Hepatology 2008;48:588-96
   PubMed Web of Science ®Google Scholar
• Roy B, Chowdhury A, Kundu S, Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 ‘null’ mutation. J Gastroenterol Hepatol 2001;16:1033-7
   PubMed Web of Science ®Google Scholar
• Huang YS, Su WJ, Huang YH, Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury. J Hepatol 2007;47:128-34
   PubMed Web of Science ®Google Scholar
• Leiro V, Fernandez-Villar A, Valverde D, Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population. Liver Int 2008;28:835-9
   PubMed Web of Science ®Google Scholar
• Ueda K, Ishitsu T, Seo T, Glutathione S-transferase M1 null genotype as a risk factor for carbamazepine-induced mild hepatotoxicity. Pharmacogenomics 2007;8:435-42
   PubMed Web of Science ®Google Scholar
• Andrade RJ, Lucena MI, Alonso A, HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease. Hepatology 2004;39:1603-12
   PubMed Web of Science ®Google Scholar
• Aithal GP, Ramsay L, Daly AK, Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity. Hepatology 2004;39:1430-40
   PubMed Web of Science ®Google Scholar
• Pachkoria K, Lucena MI, Crespo E, Analysis of IL-10, IL-4 and TNF-alpha polymorphisms in drug-induced liver injury (DILI) and its outcome. J Hepatol 2008;49:107-14
   PubMed Web of Science ®Google Scholar
• Ladero JM, Fernandez-Arquero M, Tudela JI, Single nucleotide polymorphisms and microsatellite alleles of tumor necrosis factor alpha and interleukin-10 genes and the risk of advanced chronic alcoholic liver disease. Liver 2002;22:245-51
   PubMedGoogle Scholar
• Zou W, Roth RA, Younis HS, Oxidative stress is important in the pathogenesis of liver injury induced by sulindac and lipopolysaccharide cotreatment. Toxicology 2010;272:32-8
   PubMed Web of Science ®Google Scholar
• Ong MM, Wang AS, Leow KY, Nimesulide-induced hepatic mitochondrial injury in heterozygous Sod2(+/-) mice. Free Radic Biol Med 2006;40:420-9
   PubMed Web of Science ®Google Scholar
• Lucena MI, Garcia-Martin E, Andrade RJ, Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury. Hepatology 2010;52:303-12
   PubMed Web of Science ®Google Scholar
• Strnad P, Zhou Q, Hanada S, Keratin variants predispose to acute liver failure and adverse outcome: race and ethnic associations. Gastroenterology 2010;139:828-35, 35 e1-3
   PubMed Web of Science ®Google Scholar
• Andrade RJ, Crespo E, Ulzurrun E, Polymorphic bile salt export pump transporter is a major determinant of hepatocellular Drug-Induced Liver Injury. Hepatology 2008;48:468A
   Web of Science ®Google Scholar
• Houle D, Govindaraju DR, Omholt S. Phenomics: the next challenge. Nat Rev Genet 2010;11:855-66
   PubMed Web of Science ®Google Scholar
• Garcia-Martin E. Interethnic and intraethnic variability of NAT2 single nucleotide polymorphisms. Curr Drug Metab 2008;9:487-97
   PubMed Web of Science ®Google Scholar
• Agundez JA, Ladero JM. Glutathione S-transferase GSTT1 and GSTM1 allozymes: beyond null alleles. Pharmacogenomics 2008;9:359-63
   PubMed Web of Science ®Google Scholar
• Agundez JA, Golka K, Martinez C, Unraveling ambiguous NAT2 genotyping data. Clin Chem 2008;54:1390-4
   PubMed Web of Science ®Google Scholar
• Cornejo-Garcia JA, Blanca-Lopez N, Dona I, Hypersensitivity reactions to non-steroidal anti-inflammatory drugs. Curr Drug Metab 2009;10:971-80
   PubMed Web of Science ®Google Scholar
• Dona I, Blanca-Lopez N, Cornejo-Garcia JA, Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response. Clin Exp Allergy 2010;41:86-95
   Web of Science ®Google Scholar
• Garcia-Martin E, Ayuso P, Martinez C, Histamine pharmacogenomics. Pharmacogenomics 2009;10:867-83
   PubMed Web of Science ®Google Scholar
• Garcia-Martin E, Garcia-Menaya J, Sanchez B, Polymorphisms of histamine-metabolizing enzymes and clinical manifestations of asthma and allergic rhinitis. Clin Exp Allergy 2007;37:1175-82
   PubMed Web of Science ®Google Scholar
• Garcia-Martin E, Mendoza JL, Martinez C, Severity of ulcerative colitis is associated with a polymorphism at diamine oxidase gene but not at histamine N-methyltransferase gene. World J Gastroenterol 2006;12:615-20
   PubMed Web of Science ®Google Scholar
• Gervasini G, Agundez JA, Garcia-Menaya J, Variability of the L-Histidine decarboxylase gene in allergic rhinitis. Allergy 2010;65:1576-84
   PubMed Web of Science ®Google Scholar
• Garcia-Martin E, Ayuso P, Martinez C, Improved analytical sensitivity reveals the occurrence of gender-related variability in diamine oxidase enzyme activity in healthy individuals. Clin Biochem 2007;40:1339-41
   PubMed Web of Science ®Google Scholar
• Fannin RD, Russo M, O'Connell TM, Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation. Hepatology 2010;51:227-36
   PubMed Web of Science ®Google Scholar
• Barton RH. A decade of advances in metabonomics. Expert Opin Drug Metab Toxicol 2011;7:129-36
   PubMed Web of Science ®Google Scholar